Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$40K Sell
825
-300
-27% -$14.9K 0.02% 237
2025
Q3
$53.1K Sell
1,125
-150
-12% -$7.24K 0.02% 164
2025
Q2
$61.6K Sell
1,275
-550
-30% -$28.1K 0.03% 161
2025
Q1
$101K Hold
1,825
0.05% 134
2024
Q4
$88K Hold
1,825
0.04% 164
2024
Q3
$105K Sell
1,825
-200
-10% -$10.8K 0.05% 158
2024
Q2
$98.3K Hold
2,025
0.05% 153
2024
Q1
$98.4K Buy
+2,025
New +$98.9K 0.05% 144

Other funds holding SNY

Ransom Advisory's SNY Position: Q4 2025 in Review

Ransom Advisory reduced its Sanofi (SNY) stake by 27% in Q4 2025, selling an estimated $14.9K and leaving 825 shares worth $40K. The position accounts for 0.02% of the portfolio, ranked #237.

Ransom Advisory first reported a position in SNY in Q1 2024 and has held it in 8 quarters since. The position peaked at $105K in Q3 2024. 755 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Ransom Advisory held 825 shares of Sanofi worth $40K as of Q4 2025.
  • Ransom Advisory sold 300 Sanofi shares in Q4 2025, an estimated $14.9K.
  • Sanofi made up 0.02% of Ransom Advisory's portfolio in Q4 2025, its #237 holding.
  • Ransom Advisory first reported a position in Sanofi in Q1 2024 and has held it in 8 quarters since.
  • Ransom Advisory's Sanofi position peaked at $105K in Q3 2024.
  • 755 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.